Phase 4Not yet recruitingAge-related condition
Study evaluating the effect of ARTENSIUM® cream on knee osteoarthritis pain. (ARTHROSIT)
An exploratory double-blind randomized placebo-controlled trial to evaluate the effect of ARTENSIUM® cream in the relief of pain in patients with knee osteoarthritis
- Sponsor
- Boiron (Industry)
- Enrolment
- 200 planned
- Conditions
- Gonarthrosis
- Interventions
- ARTENSIUM, crème
- Ages
- adults, older adults
- Registry
- CTIS2026-527647-18-00
Full record on the EU Clinical Trials Information System
From the registry
Main objective: To evaluate the specific therapeutic effect of ARTENSIUM® cream compared with placebo on pain in patients with symptomatic knee osteoarthritis after 7 and 14 days of treatment.
Primary outcomes
- Change in the KOOS Pain subscale score, assessed longitudinally between Day 0, Day 7, and Day 14, with the primary estimate of treatment effect at Day 14. If the patient experiences pain in both knees, only the most painful knee will be assessed.
History
Registered